Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest IBD Stories

2014-03-28 11:32:58

A novel method for distinguishing different types of bowel disease using the stool samples of patients has been created by a group of researchers in the UK. It works by analysing the chemical compounds emitted from the samples and could provide cheaper, quicker and more accurate diagnoses, at the point of care, for a group of diseases that have, up until now, been very hard to distinguish. The preliminary results of the test, which have been published today, 28 March, in IOP...

2014-03-10 16:31:55

Foundation Champions Innovation & Collaboration to Accelerate IBD Breakthroughs OAKLAND, Calif., March 10, 2014 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation's 2014 Innovations Symposium: Taming the Microbiome will take place July 15 - 16, 2014, at the Union Square Marriott in San Francisco. The annual event brings together influential and collaborative researchers and institutions, with the common goal of curing Inflammatory Bowel Disease (IBD), a disease that affects...

2014-03-03 08:32:34

CCFA Researchers Map Out Strategies to New Drugs and Individualized Therapy for Crohn's Disease and Ulcerative Colitis NEW YORK, March 3, 2014 /PRNewswire/ -- High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and...

2014-01-07 04:21:03

LONDON, January 7, 2014 /PRNewswire/ -- ~ ST10 strongly demonstrates potential to be (1) the only effective oral treatment for ferrous intolerant IDA patients and (2) an effective alternative to intravenous iron treatment ~ Shield Therapeutics (Shield), an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces strongly positive top-line data from...

2013-12-10 08:30:11

LOS ANGELES and NEW YORK, Dec. 10, 2013 /PRNewswire-USNewswire/ -- The Broad Medical Research Program, which funds innovative early-stage research into inflammatory bowel disease, will merge with the Crohn's & Colitis Foundation of America (CCFA), the two organizations announced today. (Logo: http://photos.prnewswire.com/prnh/20131210/DC30385LOGO-a) (Logo: http://photos.prnewswire.com/prnh/20131210/DC30385LOGO-b) The Broad Medical Research Program was started by The Eli and...

2013-11-26 08:27:02

- New results show BL-7040 to reduce pro-inflammatory cytokine levels and improve colon histology in IBD patients - JERUSALEM, Nov. 26, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX)(TASE:BLRX), a biopharmaceutical development company, announced today additional Phase 2a results showing significant improvement of disease measurements in biopsies taken from inflammatory bowel disease (IBD) patients treated with BL-7040, an orally available drug for treating IBD. The histological and...

2013-09-24 23:19:33

Reportbuyer.com just published a new market research report: Inflammatory Bowel Diseases: World Drug Market 2013-2023. London (PRWEB) September 24, 2013 Report Details Medicines for bowel inflammation - you explore R&D and potential sales What's the future for treating inflammatory bowel diseases (IBD)? Visiongain's updated report gives you revenue predictions from 2013, helping you stay ahead. There you find financial results, R&D trends, opportunities, and potential...

2013-08-30 23:19:10

The physicians at Los Angeles Colon and Rectal Surgical Associates (http://colon92010.com) have added a new section to their website to help assist their patients in understanding a number of colorectal diseases. The section is focused on patient education specific to the diseases of colon cancer, irritable bowel syndrome, and inflammatory bowel disease. Beverly Hills, California (PRWEB) August 30, 2013 The colorectal surgeons of Los Angeles Colon and Rectal Surgical Associates...

2013-08-13 08:26:10

BETHESDA, Md., Aug.13, 2013 /PRNewswire-USNewswire/ -- Swiss researchers report an increase risk of inflammatory bowel disease (IBD) relapse in patients during heat wave periods. The study published in The American Journal of Gastroenterology also found an increase of infectious gastroenteritis during heat waves, with the strongest impact following a 7 day lag time after the heat wave. The authors noted, "There is evidence for an increase of IBD hospital admissions by 4-6 percent...

2013-08-08 12:26:18

Foundation awards 15 grants to support cutting-edge research for Inflammatory Bowel Disease and hosts annual Innovations Symposium to promote scientific collaboration. OAKLAND, Calif., Aug. 8, 2013 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today that it has awarded 15 grants totaling $1.5 million for Inflammatory Bowel Disease (IBD) research through its Innovator and Breakthrough Awards Programs. The Foundation also hosted its second annual Innovations Symposium,...